Status:
COMPLETED
The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis
Lead Sponsor:
Chinese SLE Treatment And Research Group
Conditions:
Rheumatoid Arthritis
Satisfaction
Eligibility:
All Genders
18+ years
Brief Summary
A questionnaire for this research is designed, which initiated from TSQM-II treatment satisfaction questionnaire and based on research launched by rheumatology and immunology departments of Chinese 12...
Detailed Description
In the last decade, China has made quick progress on treatment of rheumatoid arthritis. However, the improvement of remission rate cannot fully represent needs of patients for health. To meet health d...
Eligibility Criteria
Inclusion
- Doctors - registered rheumatoid specialist physicians subordinated to the 12 designated hospitals Patients - aged over 18, confirming RA for more than 6 months
Exclusion
- Doctors - N/A Patients - with Chinese reading comprehension barriers (unable to complete the questionnaire independently), without any RA treatment
Key Trial Info
Start Date :
March 31 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2018
Estimated Enrollment :
1365 Patients enrolled
Trial Details
Trial ID
NCT03483597
Start Date
March 31 2018
End Date
April 30 2018
Last Update
August 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, China, 100730